Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial88

File Visits

Downloads
7415-31389.pdf32

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial23

Number of downloads in the range

Downloads
7415-31389.pdf10

Views

Views
September 20256
October 20252
November 20254
December 20250
January 202610
February 20260
March 20261
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • September 2025
    1
  • October 2025
    0
  • November 2025
    4
  • December 2025
    5
  • January 2026
    0
  • February 2026
    0
  • March 2026
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil5
Chile2
Argentina1
Ecuador1
Finland1
Morocco1
 

Top countries by downloads

Downloads
United States5
Finland1
 

Top cities views

Views
San Jose10
Ariquemes1
Córdoba1
Dallas1
Guayaquil1
Khouribga1
Lappeenranta1
Mucugê1
Quillota1
Rio de Janeiro1
 

Top cities by downloads

Downloads
Lappeenranta1